Overview

Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms

Status:
Unknown status
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
Gestational trophoblastic neoplasm affect women and is sensitive to chemotherapy especially methotrexate and the investigators try to find a role of surgery plus methotrexate instead of multiple doses and cycles of chemotherapy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Maher elesawi kamel elesawi
Treatments:
Calcium, Dietary
Folic Acid
Leucovorin
Levoleucovorin
Methotrexate